Iceland vs New Zealand: Estimated antiretroviral therapy coverage among people living with HIV
Iceland
88.0%
in 2025
New Zealand
88.0%
in 2025
Iceland rank
31st
New Zealand rank
31st
Estimated antiretroviral therapy coverage among people living with HIV over time
- Iceland
- New Zealand
How they compare
Iceland currently reports 88.0% against 88.0% in New Zealand, a difference of 0.0%.
Across all 26 years both countries report, New Zealand has been ahead every year.
Iceland ranks 31st and New Zealand ranks 31st of 143 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.7% | 47.0% | 2.3% | New Zealand |
| 2010s | 61.1% | 70.3% | 9.2% | New Zealand |
| 2020s | 80.7% | 85.3% | 4.7% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Iceland or New Zealand?
- Iceland, at 88.0% against 88.0% in New Zealand as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Iceland and New Zealand?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and New Zealand?
- 26 years are reported by both, from 2000 to 2025.
- How do Iceland and New Zealand rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Iceland ranks 31st and New Zealand ranks 31st of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.